Company: MDCXW
Filing Date: 2025-06-06
Form Type: 424B3
Source: 0001062993-25-011087
Chunk: 4

Company: Medicus Pharma Ltd.
Filing Date: 2025-06-06
Form: 424B3
Chunk 4
---
2025, neither the Company, nor any party on its behalf, consulted with KPMG regarding either (i) the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered with respect to the Company's financial statements, and no written reports or oral advice were provided to the Company by KPMG that was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue or (ii) any matter that was either the subject of (a) a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K or (b) a reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.

| Item 9.01 | Financial Statements and Exhibits |

(d) Exhibits

| Exhibit | Description                                                                 |
| 16.1    | Letter from EisnerAmper LLP                                                 |
| 104     | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| MEDICUS PHARMA LTD. |                                                |
| By:                 | /s/ Raza Bokhari                               |
| Name:               | Dr. Raza Bokhari                               |
| Title:              | Executive Chairman and Chief Executive Officer |

Dated: June 5, 2025

Exhibit 16.1

June 5, 2025

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Ladies and Gentlemen:

We have read Item 4.01 of Form 8-K dated June 5, 2025 of Medicus Pharma Ltd. and are in agreement with the statements contained therein as it regards our firm. We have no basis to agree or disagree with other statements of the registrant contained in Item 4.01.

Sincerely,

/s/ EisnerAmper LLP

EisnerAmper LLP